cupcakes Lexaria Bioscience seeing increased demand for its DehydraTECH drug delivery system

DehydraTECH masks unwanted taste, improves onset speed and increases bioavailability of active...

2 days, 17 hours ago
Deep dive

XPhyto is progressing its scientific approach to cannabis-based medicine and...

The bioscience company and its exclusive diagnostic partner, 3a-Diagnostics GmbH, are developing...

5 days, 12 hours ago
Deep dive

InnoCan Pharma is taking a true pharmaceutical approach to commercializing...

InnoCan is developing a revolutionary injectable CBD delivery system that facilitates targeted,...

1 week, 3 days ago
Deep dive

FSD Pharma throws resources behind legacy anti-inflammatory drug as...

The company plans a Phase 2 study of FSD201 in more than 300 COVID-19 patients in October this year

2 weeks ago

Antibe’s breakthrough osteoarthritis pain relief drug in the spotlight on...

The company’s lead drug otenaproxesul, formerly known as ATB-346, could be a home run if it...

2 weeks ago

CytoDyn provide update on their path to approval for treatment of COVID-19

CytoDyn (OTCQB: CYDY) CEO Nader Pourhassan joined Steve Darling from Proactive to provide an update on how and when they expect to have approval for Leronlimab for Covid treatment.  Pourhassan also told Proactive about what the recent decision by the FDA to approve Remdesivir as a...

2 days, 9 hours ago

Join Proactive

Get ahead of the curve

First with the equities news

Get our market previews and stories before the main networks.

Widest with the analysis

Not just the FTSE. Read about
opportunities from the whole
equities market.

Closest to the source

Hear directors at first-hand
or meet them in person at our events.

In at the start

Watch IPOs and access on the same terms as the institutions.